|
End-of-day quote
Taipei Exchange
28/08/2026
|
5-day change | 1st Jan Change | ||
| 22.60 TWD | -0.66% |
|
0.00% | -12.23% |
| 08-13 | GlycoNex Incorporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-03 | GlycoNex Inc Doses First Patient In Phase I Trial Of GNX1021 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 80.31M | - | - | - | - | - |
| 50.47B | |||||
| 44.56B | - | - | - | - | - |
| 43.08B | |||||
| 41.7B | |||||
| 33.21B |
Select your edition
All financial news and data tailored to specific country editions
